Chylothorax secondary to lymphoma: diagnosis and management in a clinical case, Paraguay 2024

Authors

DOI:

https://doi.org/10.53732/rccsalud/e8914

Keywords:

chylothorax, lymphoma non-hodgkin, pleural effusion, pleurodesis, octreotide, case reports

Abstract

Chylothorax is a rare cause of pleural effusion characterized by the accumulation of chyle in the pleural space due to rupture or obstruction of the thoracic duct or its tributaries. In adults, the most common etiology is malignancy, particularly lymphomas, which account for approximately 70% of non-traumatic cases. We report the case of a 37-year-old woman presenting with progressive dyspnea and interscapular chest pain without a history of trauma. Pleural fluid analysis revealed triglycerides of 751 mg/dL and cholesterol of 67 mg/dL, consistent with chylothorax. The patient was initially managed with pleural drainage; however, due to persistent output, a right thoracotomy with decortication, lavage, and pleurodesis was performed. Histopathological examination confirmed non-Hodgkin lymphoma as the underlying cause. The management of chylothorax focuses on treating the underlying disease and may include conservative measures (fat-free diet, medium-chain triglycerides, octreotide) or surgical intervention for persistent leakage. This case highlights the importance of early diagnosis and a multidisciplinary therapeutic approach in patients with chylothorax associated with lymphoproliferative neoplasms. Spontaneous chylothorax secondary to lymphoma represents a diagnostic and therapeutic challenge. Timely recognition and comprehensive management are essential to reduce morbidity and improve patient outcomes.

References

Botana-Rial MI, Leiro-Fernández V, Represas-Represas C, López González FJ, Porcel JM, Rodríguez M, et al. Diagnosis and treatment of pleural effusion. Arch Bronconeumol. 2023;59(1):27-35. https://doi.org/10.1016/j.arbres.2022.09.017

Jacobs B, Sheikh G, Youness HA, Keddissi JI, Abdo T. Diagnosis and management of malignant pleural effusion: a decade in review. Diagnostics (Basel). 2022;12(4):1016. https://doi.org/10.3390/diagnostics12041016

Bhatnagar M, Fisher A, Ramsaroop S, Carter A, Pippard B. Chylothorax: pathophysiology, diagnosis, and management—a comprehensive review. J Thorac Dis. 2024;16(2):1645–1661. https://doi.org/10.21037/jtd-23-1636

Ur Rehman K, Sivakumar P. Non-traumatic chylothorax: diagnostic and therapeutic strategies. Breathe (Sheff). 2022;18(2):210163. https://doi.org/10.1183/20734735.0163-2021

Porcel JM, Bielsa S, Civit C, Aujayeb A, Janssen J, Bodtger U, et al. Clinical characteristics of chylothorax: results from the International Collaborative Effusion database. ERJ Open Res. 2023;9(5):00091-2023. https://doi.org/10.1183/23120541.00091-2023

Pospíškova J, Smolej L, Belada D, Simkovic M, Motyckova M, Sykorova A, et al. Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders. Orphanet J Rare Dis. 2019;14(1):9. https://doi.org/10.1186/s13023-018-0991-3

Wagenpfeil J, Hoß K, Henkel A, Kütting D, Luetkens JA, Feldmann G, et al. Interventional treatment of refractory non-traumatic chylous effusions in patients with lymphoproliferative disorders. Clin Exp Med. 2024;24:63. https://doi.org/10.1007/s10238-024-01312-4

Litvin R, Razok A, Dasgupta M, Martinez Trevino E, Saad Eldin M, Fakhran S. Nontraumatic chylothorax: a case series from a safety-net hospital. Ann Intern Med Clin Cases. 2023;2(9). https://doi.org/10.7326/aimcc.2023.0119

Darshini V Jr, Arshad AM, Ayub II, Dhanasekar T. A case of chylothorax in non-Hodgkin lymphoma. Cureus. 2024;16(10):e71957. https://doi.org/10.7759/cureus.71957

Wijaya SY, Koesoemoprodjo W. Indonesian female with bilateral chylothorax and mediastinal non-Hodgkin lymphoma: a case report. Int J Surg Case Rep. 2023;102:107827. https://doi.org/10.1016/j.ijscr.2022.107827

Benjamin J, O’Leary C, Hur S, Gurevich A, Klein WM, Itkin M. Imaging and interventions for lymphatic and lymphatic-related disorders. Radiology. 2023;307(3):e220231. https://doi.org/10.1148/radiol.220231

Kim EY, Hwang HS, Lee HY, Cho JH, Kim HK, Lee KS, et al. Anatomic and functional evaluation of central lymphatics with noninvasive magnetic resonance lymphangiography. Medicine (Baltimore). 2016;95(12):e3109. https://doi.org/10.1097/MD.0000000000003109

Gurevich A, Hur S, Singhal S, DiBardino D, Haas AR, Hansen-Flaschen JH, et al. Nontraumatic chylothorax and chylopericardium: diagnosis and treatment using an algorithmic approach based on novel lymphatic imaging. Ann Am Thorac Soc. 2022;19(5):756-762. https://doi.org/10.1513/AnnalsATS.202103-262OC

Nadolski GJ, Itkin M. Thoracic duct embolization for nontraumatic chylous effusion: experience in 34 patients. Chest. 2013;143(1):158-163. https://doi.org/10.1378/chest.12-0526

Kim PH, Tsauo J, Shin JH. Lymphatic interventions for chylothorax: a systematic review and meta-analysis. J Vasc Interv Radiol. 2018;29(2):194–202.e4. https://doi.org/10.1016/j.jvir.2017.10.006

Published

2026-01-31

How to Cite

1.
Nuñez Guerrero IA, Benítez Ríos HJ, Silvero Prieto ST, Fernández González D. Chylothorax secondary to lymphoma: diagnosis and management in a clinical case, Paraguay 2024. Rev. cient. cienc. salud [Internet]. 2026 Jan. 31 [cited 2026 Feb. 13];8:01-7. Available from: https://revistascientificas.upacifico.edu.py/index.php/PublicacionesUP_Salud/article/view/914